Exchange: NASDAQ·Updated 04:02 AM EDT
AARD logo

AARD Aardvark Therapeutics Inc

$4.76
$0.30
(5.93%)
Pre-Market
Prev Close $5.06
EarningsNov 12
Mkt Cap$110.74M
Vol72.00

About AARD

Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.
48

Neutral Sentiment

How do you feel about AARD?

Advertisement|Remove ads.